Journal article
A randomized placebo-controlled trial of vitamin D supplementation for reduction of mortality and cancer: Statistical analysis plan for the D-Health Trial
M Waterhouse, DR English, BK Armstrong, C Baxter, B Duarte Romero, PR Ebeling, G Hartel, MG Kimlin, DSA McLeod, RL O'Connell, JC van der Pols, AJ Venn, PM Webb, DC Whiteman, RE Neale
Contemporary Clinical Trials Communications | ELSEVIER INC | Published : 2019
Abstract
Background: Many observational studies have reported an association between vitamin D and non-skeletal health outcomes. The D-Health Trial was launched to determine if supplementing the older population with high monthly doses of Vitamin D can prevent cancer and premature mortality. The intervention is ongoing but here we provide a detailed statistical analysis plan for the primary and secondary outcomes of the D-Health Trial. Methods/design: The D-Health Trial is a double-blind, randomized, placebo-controlled trial. Between February 2014 and May 2015, 21,315 people were randomized in a 1:1 ratio to receive monthly doses of either 60,000 IU of cholecalciferol (vitamin D 3 ) or placebo for fi..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The D-Health Trial is funded by a National Health and Medical Research Council project grant (APP1046681). RE Neale, DSA McLeod, PM Webb and DC Whiteman are supported by fellowships from the NHMRC.